ENGN: enGene Holdings Inc Kompaniya qiymatining sof foydaga nisbati

enGene Corp - ENGN emitenti grafik logotipi

enGene Holdings Inc. (ENGN) rahbariyati kodlanmagan DNK tadqiqotlarini rivojlantirish va strategik hamkorlarni qidirish orqali o'zining bozor mavqeini mustahkamlashni maqsad qilgan. Kompaniyaning daromadlari qovuq saratoni uchun yuqori marjali davolash vositasi bo'lgan EG-70 ning tijoratlashtirilishi hisobiga oshadi. GURU.Markets dagi narxlar dinamikasi -0.90 miqdoridagi P/E ko'rsatkichini aks ettirmoqda. Shu bilan birga, biofarmatsevtika biznesi ob'ektlarning energiya samaradorligini oshirish va xavfli chiqindilarni utilizatsiya qilish orqali ESG standartlarini joriy qilmoqda.

enGene (ENGN) Narxning foydaga nisbati: 21.02.2024 - 18.11.2026 davri uchun

enGene Corp (ENGN) kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning har tomonlama tahlili:enGene ENGN
enGene Bio brend mahsuloti

P/E ko'rsatkichi biznesning bozor qiymatini uning yillik sof foydasi nisbatida belgilaydi. Ushbu koeffitsient kapitalizatsiyaning foydaga bo'linishi orqali hisoblanadi va investorlarning foyda birligi uchun qanchalik ortiqcha to'layotganini ko'rsatadi. Kompaniyaning P/E multiplikatori tarixini tahlil qilish orqali bozor kutganlarini uning raqobatchilari bilan solishtirib baholash mumkin. enGene Holdings Inc. (ENGN) uchun ushbu metrikaning yuqori tebranishlari FDA risklarini va gen yetkazib berish tizimlari ishlab chiqarishini kengaytirishning murakkabliklarini aks ettiradi.

Muhim raqobatchilar

P/E multiplikatori Argenx|Narx-foyda koeffitsiyenti BNTX (BioNTech Group)|ABVX (abivax.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (admabiologics.com)|Biznesning o‘zini qoplash muddati protagonist-inc.com (PTGX)|IMVT - Narxning foydaga nisbati|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Narx-foyda koeffitsiyenti|Grifols Biemat (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotechnologies|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori auriniapharma.com|Narxning foydaga nisbati BioCryst Pharmaceuticals Inc (BCRX)|Vera Therapeutics - Narx-foyda multiplikatori|P/E multiplikatori DNTH (dianthustx.com)|Pharvaris Pharma (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Biologics - P/E multiplikatori|tourmalinebio.com - Bozor narxining sof foydaga nisbati|Precigen (PGEN) - Narxning foydaga nisbati|Pharming Group - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Nektar Therapeutics Inc|UPB (Upstream Pharma) - Bozor narxining sof foydaga nisbati|P/E multiplikatori ZBIO|P/E multiplikatori immunome.com (IMNM)|P/E multiplikatori GOSS (gossamerbio.com)|Biznesning o‘zini qoplash muddati KalVista Pharma (KALV)|SEPN - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Pieris Pharmaceuticals PVLA|SVRA (Savara Inc.) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati RIGL (Rigel Pharmaceuticals)|ANAB (AnaptysBio) - P/E multiplikatori|ATXS (Astria Therapeutics, Inc.) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati RAPT Therapeutics (RAPT)|JBIO (Aerovate) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ACRS (Aclaris Therapeutics)|Kompaniya qiymatining sof foydaga nisbati KYTX|Tiziana Life Sciences - P/E multiplikatori|CABA: Narxning foydaga nisbati|VTYX: P/E multiplikatori|THTX (Theratechnologies, Inc) - Narxning foydaga nisbati|AVTX (Avalo Therapeutics, Inc.) - P/E multiplikatori|P/E multiplikatori Eledon Pharmaceuticals|Narxning foydaga nisbati Agenus Inc. (AGEN)|Narx-foyda koeffitsiyenti Climb Bio Inc. CLYM|P/E multiplikatori ZURA (Zura Bio Ltd)|ATYR - Narx-foyda koeffitsiyenti|ADAG - Narxning foydaga nisbati|IMA - P/E multiplikatori|STTK: P/E multiplikatori|Equillium Bio (EQ) - P/E multiplikatori|CNTB (connectbiopharm.com) - P/E multiplikatori|IMUX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ATRA|P/E multiplikatori InflaRx NV (IFRX)|X4 Pharmaceuticals, Inc. (XFOR) - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori adicetbio.com ACET|Celularity - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati INMB (INmune Bio Corp)|BRNS (Barinthus Bio) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati KZR (Kezar Life Sciences)|Narxning foydaga nisbati SAB Biotherapeutics Inc.|Akari Therapeutics Plc - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti ENLV (Enlivex Therapeutics Ltd.)|Narx-foyda koeffitsiyenti Q32 Bio Inc QTTB|Narxning foydaga nisbati geovax.com GOVX|P/E multiplikatori edesabiotech.com EDSA|iBio Corporation - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CARM (carismatx.com)|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Bolt Bio (BOLT) - P/E multiplikatori|HCWB (HCW Biologics Inc) - P/E multiplikatori|Narx-foyda koeffitsiyenti Aptevo Therapeutics (APVO)|P/E multiplikatori AIM|Bozor narxining sof foydaga nisbati ADTX|P/E multiplikatori GRI (GRI Bio Corporation)|P/E multiplikatori XORTX Corp XRTX|HIND - Narxning foydaga nisbati|Revelation Biosciences (REVB) - Narx-foyda koeffitsiyenti|INDP (Indaptus Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Scinai Immunotherapeutics Ltd (SCNI) - P/E multiplikatori|CALI (CalciMedica Inc) - P/E multiplikatori|affimed.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati allakos.com (ALLK)|P/E multiplikatori HOOKIPA Pharma, Inc. (HOOK)|IGM Biosciences Inc. - Narx-foyda koeffitsiyenti|iTeos Therapeutics, Inc. (ITOS) - Kapitalizatsiyaning foydaga nisbati|OCEA: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati TCBP (TC BioPharm (Holdings) PLC)|THRD: P/E multiplikatori